Max Healthcare Institute Ltd

Stage 4 · Declining · week 2

As of 9 Oct 2026, Max Healthcare Institute is in Stage 4 — declining, a downtrend, in week 2 (since 1 Oct 2026). It closed at ₹884, 27.0% below its 52-week high and below its 200-day average, which is falling. In Health Care, 44.6% of stocks are in Stage 2.

Max Healthcare Institute Limited provides medical and healthcare services in India. More about the company

₹883.8
+1.19% today
₹86,021 Cr · Large cap
Market Neutral — FadingHealth Care 44.6% in Stage 2-2.6 pts / 20dHospitals & Diagnostic Centres 32.3%-6.5 pts

Pro read

Pro

Our read

Declining — below its long-term trend

Setup score

—

Momentum

Steady

Edge

—

Is MAXHEALTH early, or has it already run? Pro answers that for every NSE stock, after every close.

₹2,999 · 12 months₹1,999 · 6 months
Loading price chart…
vs 52W High
-27.0%
₹873.4 lo₹1,211 hi
27.0% below 52W high — ongoing decline
In Stage 4, distance from the 52W high reflects ongoing decline — not a discount. Avoid catching falling knives.
Stage Maturity
Week 2
1w13w26w
Week 2 — early Stage 4 decline
How long this stock has been in Stage 4 decline. The longer the downtrend, the more entrenched the selling pressure — there's no 'bottom' time to buy.
vs 200 DMA
-14.1%
200 DMA: ₹1,029.2 · sloping down
In Stage 4, the stock is below its 200 DMA — the hallmark of a downtrend. No long positions warranted until this reverses structurally.
Rel Volume
2.35x
vs 50-day avg
High volume on down days in Stage 4 confirms institutional selling. Low volume bounces are typical — they lack real buyers and should not be mistaken for reversals.
Trend Health
↓
MA20 rolling over · -3.5% vs MA50 -4.3%
Two-layer momentum read: the glyph shows whether the 20-day MA is rising (↑/↗), flat (→), or rolling over (↓). The ⇈ flag fires when the 20-day MA is pulling away from the 50-day MA — short-term momentum building on top of the longer trend. Best when both glyphs agree.
1M
-11.0%
3M
-20.2%
6M
-6.1%
YTD
-17.8%
1Y
-20.6%
Sector
Health Care
↓ Peaking
Stage 2%
44.6%
20d Δ
-2.6pp
1M return
-4.9%
3M return
+0.2%
Sector Stage-2 % · last 20 days
Sector has 74 Stage 2 leaders. See Health Care Stage 2 →
Industry
Hospitals & Diagnostic Centres
↓ Peaking
Stage 2%
32.3%
20d Δ
-6.5pp
1M return
-8.1%
3M return
-10.8%
Industry Stage-2 % · last 20 days
Industry has 9 Stage 2 leaders. See Hospitals & Diagnostic Centres Stage 2 →
Stage Cycle Timeline2023-07-14 → 2026-10-09
S2 27w
S2 15w
S2 22w
S2 21w
S4 30w
2023-07-142026-10-09
S1S2S3S4Setup score (0–10, dashed line at 5)
S2 7w → S3 9w → S2 27w → S3 3w → S2 15w → S3 1w → S2 22w → S3 7w → S2 21w → S3 10w → S4 30w → S1 5w → S2 6w → S3 3w → S4 1w current
Total tracked: 168 weeks across 15 stage runs.
Scan Membership
Breakout Watch
Latest: 2026-07-24
4 appearances in last 60 days. First seen: 2024-06-03.
Stocks that stay in the scan for 13+ weeks are in the highest observed-return cohort — they keep qualifying because the structure remains intact, not by luck. Persistence in the scan is itself a quality signal.
Recent Stage Timeline
2026-10-09S4
Wk 2 · Vol 2.35x
2026-10-08S4
Wk 1 · Vol 0.99x
2026-10-07S4
Wk 1 · Vol 0.89x
2026-10-06S4
Wk 1 · Vol 1.08x
2026-10-05S4
Wk 1 · Vol 1.43x
2026-10-01S43→4
Wk 1 · Vol 2.58x
2026-09-30S3
Wk 4 · Vol 7.36x
2026-09-29S3
Wk 4 · Vol 1.41x
2026-09-28S3
Wk 3 · Vol 1.45x
2026-09-25S3
Wk 3 · Vol 1.05x
2026-09-24S3
Wk 3 · Vol 1.38x
2026-09-23S3
Wk 3 · Vol 0.61x
Sector Peers — Stage 2All →
BAFNAPH
wk 18 · 0.0% from hi
8.6
ZIMLAB
wk 22 · 0.0% from hi
8.3
KILITCH
wk 2 · -7.3% from hi
8.3
SMSPHARMA
wk 3 · -8.0% from hi
8.3
RPGLIFE
wk 16 · -12.0% from hi
7.6
Moving averages & range
50 DMA
₹1,013
200 DMA
₹1,029.2
52W High
₹1,211
52W Low
₹873.4
5D Low
₹873.4
Resistance levels (recent highs)
20d High
₹1,068
60d High
₹1,124.8
120d High
₹1,153.4
250d High
₹1,211
Next resistance
+20.8%
to 20d High
Ask the Market AI about MAXHEALTHAsk →
P/E (TTM)
67.5
Forward 40.8
Earnings Growth (YoY)
+7.3%
Revenue +12.2%
ROE
+14.3%
Profit margin +17.2%
Dividend Yield
0.15%
P/B 9.7
About this companyHealth Care· Hospitals & Diagnostic Centres

Max Healthcare Institute Limited provides medical and healthcare services in India. It offers services in various specialties, including cardiac sciences, orthopedics, oncology, renal sciences, neurosciences, minimal access and general surgery, pulmonology, obstetrics, gynecology, pediatrics, and nephrology, liver and biliary sciences, gastroenterology and Gi surgery, plastic and reconstructive surgery, and organ transplants, as well as ear, nose, and throat. The company also provides Max@Home, a platform that offers health and wellness services at home; and MaxLab, which provides diagnostic services to patients outside its network of hospitals through various channels comprising third-party hospital laboratory management. It operates through a network of healthcare facilities, including hospitals and medical centres. The company was incorporated in 2001 and is based in Gurugram, India.

Visit company website →

All analytics based on EOD data. Data as of 2026-10-09. Past data patterns are not indicative of future results. This page is a data analytics tool only.